Monument Capital Management’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-3,028
Closed 147
2017
Q4
$0 Buy
+3,028
New ﹤0.01% 128

Monument Capital Management's ECTE Position: Q1 2018 in Review

Monument Capital Management sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q1 2018, closing a stake of 3,028 shares.

Monument Capital Management first reported a position in ECTE in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 0 funds tracked by Wall St. Rank hold ECTE as of Q1 2018.

  • Monument Capital Management reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q1 2018 after selling out during the quarter.
  • Monument Capital Management sold 3,028 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q1 2018.
  • Monument Capital Management first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q4 2017 and held it in 1 quarter.
  • Monument Capital Management's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $0 in Q4 2017.
  • 0 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q1 2018.

Based on Monument Capital Management's 13F filing for Q1 2018, filed 17 Apr 2018.